Ductal Breast Carcinoma
📧 Sign up to get email alerts when something new happens for Ductal Breast Carcinoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-02-15Clinical Trial Update: G1T38, a CDK 4/6 Inhibitor, in Combination With Fulvestrant in Hormone Receptor-Positive, HER2-Negative Locally Advanced or Metastatic Breast Cancer [Phase 1, Phase 2]
A phase 1/2 clinical trial evaluating G1T38 (a CDK 4/6 inhibitor) in combination with fulvestrant for HR-positive, HER2-negative locally adv…